Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Harnesses, Slings, Carts, and Mobility Aids in Cancer Care
A properly selected and fitted aid can support transfers or walking, while a poor fit can create pain, pressure injury, falls, or caregiver strain.
Read moreHome-Environment Adaptation for Weak or Painful Oncology Patients
Small environmental changes can reduce falls, painful effort, and caregiver lifting while preserving access to basic needs and social contact.
Read moreCancer-Related Fatigue and Activity Pacing
Activity pacing balances movement and rest around disease, anemia, treatment, pain, cardiopulmonary status, sleep, and what the patient values.
Read more
Medicinal Mushroom Extracts: Product-Specific Oncology Evidence
Mushroom products differ by species, extracted fraction, standardization, contaminants, and evidence; the word mushroom does not identify a tested intervention.
Read more
Probiotics and Synbiotics During Cancer Treatment: Strain-Specific Evidence
Probiotic effects are strain-, combination-, product-, storage-, and condition-specific, and immune compromise changes the safety conversation.
Read more
Treatment Goals, Time, Cost, and Contingency Planning
A useful oncology plan makes the intended goal, expected care burden, financial boundaries, decision checkpoints, and backup options explicit without treating cost or caregiver limits as a failure.
Read moreVeterinary Cancer Clinical Trials: Eligibility, Consent, and Alternatives
A clinical trial may offer structured access to an investigational strategy or answer an important research question, but listing, enrollment, or novelty does not mean the study is…
Read moreNamed profile I’m-Yunity PSP: Canine Product ProfileRepresentative category illustration – no product packaging is shown.I’m-Yunity PSP: Canine Product Profile
I'm-Yunity is a named branded product for Dogs; manufacturer positioning must be kept separate from independent clinical evidence.
Read more
Named profile Piroxicam in Veterinary Oncology: NSAID Evidence and Interaction SafetyRepresentative category illustration – no product packaging is shown.Piroxicam in Veterinary Oncology: NSAID Evidence and Interaction Safety
piroxicam is covered as nonsteroidal anti-inflammatory drug used extra-label in selected veterinary oncology contexts, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Temozolomide in Veterinary Oncology: Oral Alkylator and Evidence BoundaryRepresentative category illustration – no product packaging is shown.Temozolomide in Veterinary Oncology: Oral Alkylator and Evidence Boundary
temozolomide is covered as triazene antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease ProfileRepresentative category illustration – no product packaging is shown.Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease Profile
hydroxyurea is covered as ribonucleotide-reductase inhibitors; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety ProfileRepresentative category illustration – no product packaging is shown.Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety Profile
procarbazine is covered as methylhydrazine antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more